ZBH
Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings Inc historical holders
total: 14
Causeway Capital Management Zimmer Biomet Holdings Inc transactions over time
- Total transactions:
- 26
- New positions:
- 2
- Sold out:
- 1
- Added:
- 12
- Reduced:
- 11
- Held since:
- 2021 Q4
- Held for:
- 19 quarters
- Latest activity:
- 2026 Q2
Sarah Ketterer has been an institutional investor in Zimmer Biomet Holdings Inc (ZBH) since 2018 Q2. According to 2026 Q2 report, Sarah Ketterer holds 788,810 shares with a market value of roughly $67.91M representing 0.74% of their equity portfolio. The fund/company first acquired ZBH in 2018 Q2, initially purchasing about 1.19M shares. Sarah Ketterer later completely sold out the position and reinvested in ZBH again in 2021 Q4. Since the initial investment, Causeway Capital Management has made 25 more transactions in this position.
Does Sarah Ketterer still hold ZBH?
Yes, Sarah Ketterer continues to hold Zimmer Biomet Holdings Inc (ZBH). According to their 2026 Q2 report, they maintain a position of 788,810 shares valued at approximately $67.91M, representing 0.74% of their equity portfolio.
When did Sarah Ketterer first invest in ZBH?
Sarah Ketterer first invested in Zimmer Biomet Holdings Inc (ZBH) in 2018 Q2 at the reported quarter-end price of $111.44 per share, acquiring 1,187,863 shares in their initial purchase.
What is Sarah Ketterer's average cost basis for ZBH?
Based on historical transaction data, Sarah Ketterer's estimated cost basis for Zimmer Biomet Holdings Inc (ZBH) is approximately $114.88 per share. This represents their average reported price* across all buy transactions.
Has Sarah Ketterer reinvested in ZBH after selling?
Yes, Sarah Ketterer has shown renewed interest in Zimmer Biomet Holdings Inc (ZBH). After completely selling their position, they reinitiated an investment in 2021 Q4, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $114.88
- Weighted AVG sell price:
- $115.48
ZBH transactions history by Causeway Capital Management
26 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.74%
|
788,810
|
$86.09
|
$67,908,650
|
-2.39% (-19,300)
|
-0.02%
|
|
2026 Q1
|
0.90%
|
808,110
|
$90.42
|
$73,069,309
|
+10.93% (+79,612)
|
+0.09%
|
|
2025 Q4
|
0.90%
|
728,498
|
$89.92
|
$65,506,589
|
+25.22% (+146,719)
|
+0.18%
|
|
2025 Q3
|
0.76%
|
581,779
|
$98.50
|
$57,305,179
|
+0.61% (+3,541)
|
+0%
|
|
2025 Q2
|
0.83%
|
578,238
|
$91.21
|
$52,741,023
|
-28.21% (-227,271)
|
-0.43%
|
|
2025 Q1
|
1.91%
|
805,509
|
$113.18
|
$91,167,554
|
+4.62% (+35,577)
|
+0.08%
|
|
2024 Q4
|
1.85%
|
769,932
|
$105.63
|
$81,327,915
|
-3.07% (-24,356)
|
-0.06%
|
|
2024 Q3
|
2.11%
|
794,288
|
$107.95
|
$85,743,364
|
+20.20% (+133,482)
|
+0.35%
|
|
2024 Q2
|
1.96%
|
660,806
|
$108.53
|
$71,717,198
|
+30.53% (+154,551)
|
+0.46%
|
|
2024 Q1
|
1.75%
|
506,255
|
$132.05
|
$66,849,961
|
-10.34% (-58,414)
|
-0.2%
|
|
2023 Q4
|
1.75%
|
$121.70
|
+39.13% (+158,806)
|
|||
|
2023 Q3
|
1.20%
|
$112.22
|
+79.57% (+179,845)
|
|||
|
2023 Q2
|
0.87%
|
$145.60
|
-46.68% (-197,872)
|
|||
|
2023 Q1
|
1.31%
|
$129.20
|
-1.87% (-8,072)
|
|||
|
2022 Q4
|
1.60%
|
$127.50
|
-5.93% (-27,247)
|
|||
|
2022 Q3
|
1.35%
|
$104.55
|
-11.99% (-62,564)
|
|||
|
2022 Q2
|
1.37%
|
$105.06
|
-6.19% (-34,425)
|
|||
|
2022 Q1
|
1.70%
|
$127.90
|
+129.96% (+314,335)
|
|||
|
2021 Q4
|
0.68%
|
$127.04
|
new
|
|||
|
2019 Q4
|
0.00%
|
$137.27
|
-100% (-1,009,417)
|
|||
|
2019 Q3
|
1.65%
|
$137.27
|
-8.70% (-96,248)
|
|||
|
2019 Q2
|
1.42%
|
$117.74
|
+5.43% (+56,992)
|
|||
|
2019 Q1
|
1.35%
|
$127.70
|
-20.28% (-266,790)
|
|||
|
2018 Q4
|
1.63%
|
$103.72
|
+8.50% (+103,001)
|
|||
|
2018 Q3
|
1.60%
|
$131.47
|
+2.07% (+24,599)
|
|||
|
2018 Q2
|
1.34%
|
$111.44
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.